Critical Reviews in Oncology Hematology

Papers
(The H4-Index of Critical Reviews in Oncology Hematology is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Harnessing tumor metabolism during cancer treatment: A narrative review of emerging dietary approaches180
Navigating management of localized prostate cancer in the geriatric population168
Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II143
Efficacy of PD-1/PD-L1 immunotherapy on brain metastatic non-small-cell lung cancer and treatment-related adverse events: A systematic review121
Skin barrier dysfunction in cutaneous T-cell lymphoma: From pathogenic mechanism of barrier damage to treatment117
A bone paradigm challenging the standard model of myeloma oncogenesis105
Editorial Board87
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm83
The role of cGAS-STING in remodeling the tumor immune microenvironment induced by radiotherapy79
Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting70
The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth66
Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients63
Letter to the Editor regarding the article “A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs app60
Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies?60
Dysregulation of systemic immunity in colorectal cancer and its clinical applications as biomarkers and therapeutics59
Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?59
Current status of locally advanced rectal cancer therapy and future prospects56
Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models54
Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis53
Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions52
Stereotactic body radiation therapy versus conventional external beam radiation therapy for painful bone metastases: A systematic review and meta-analysis of randomized trials50
Advancing tumor vaccines: Overcoming TME challenges, delivery strategies, and biomaterial-based vaccine for enhanced immunotherapy50
A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer50
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study50
Instruments and scales for the evaluation of acute radiation dermatitis: A systematic review46
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies45
Systemic immune-inflammation index as a predictor of survival in non-small cell lung cancer patients undergoing immune checkpoint inhibition: A systematic review and meta-analysis42
Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials41
Chemotherapy, immunotherapy, and targeted therapy for osteosarcoma: Recent advancements40
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era40
Neoadjuvant therapy for muscle-invasive bladder cancer: Current clinical scenario, future perspectives, and unsolved questions38
ESO's career development program (2002-2021): Presentation and evaluation38
Immunotherapy in OSCC: Current trend and challenges38
Effect of exercise on functional capacity in patients with advanced cancer: A meta-analysis of randomized controlled trials38
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer38
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis38
Editorial Board37
0.050384998321533